OBIO financials
Orchestra BioMed (OBIO) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
OBIO income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $33.48M | $33.29M | -$51.81M | -$52.95M | -1.11 |
| 2024 | $2.64M | $2.43M | -$64.30M | -$61.02M | -1.66 |
| 2023 | $2.76M | $2.57M | -$51.51M | -$49.12M | -1.48 |
| 2022 | $3.53M | $3.32M | -$32.66M | -$33.61M | -2.24 |
| 2021 | – | – | -$394.76K | -$378.75K | -0.02 |
- OBIO revenue was $33.48M in fiscal 2025, net income -$52.95M.
Updated 2026-11-14 00:53 UTC